These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20418899)

  • 1. Adenovirus-mediated LIGHT gene modification in murine B-cell lymphoma elicits a potent antitumor effect.
    Hu G; Liu Y; Li H; Zhao D; Yang L; Shen J; Hong X; Cao X; Wang Q
    Cell Mol Immunol; 2010 Jul; 7(4):296-305. PubMed ID: 20418899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of potent anti-tumor immunity by direct injection of Ad-LIGHT at the site of tumor inoculation.
    Zhang J; Wang Q; Zhao D; Cao X
    Cytotherapy; 2007; 9(4):386-96. PubMed ID: 17573614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with a recombinant adenovirus encoding a lymphoma idiotype: induction of tumor-protective immunity and identification of an idiotype-specific T cell epitope.
    Armstrong AC; Dermime S; Allinson CG; Bhattacharyya T; Mulryan K; Gonzalez KR; Stern PL; Hawkins RE
    J Immunol; 2002 Apr; 168(8):3983-91. PubMed ID: 11937555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-1BBL cooperates with B7-1 and B7-2 in converting a B cell lymphoma cell line into a long-lasting antitumor vaccine.
    Guinn BA; DeBenedette MA; Watts TH; Berinstein NL
    J Immunol; 1999 Apr; 162(8):5003-10. PubMed ID: 10202049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adeno-associated virus-mediated local delivery of LIGHT suppresses tumorigenesis in a murine cervical cancer model.
    Maitituoheti M; Li Y; Wang W; Wang W; Han L; Yang R; Wang T; Wu Z; Ma D; Wang S
    J Immunother; 2011 Oct; 34(8):581-7. PubMed ID: 21904218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD40-independent natural killer-cell help promotes dendritic cell vaccine-induced T-cell immunity against endogenous B-cell lymphoma.
    Hömberg N; Adam C; Riedel T; Brenner C; Flatley A; Röcken M; Mocikat R
    Int J Cancer; 2014 Dec; 135(12):2825-33. PubMed ID: 24771135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CpG oligodeoxynucleotides enhance the capacity of adenovirus-mediated CD154 gene transfer to generate effective B-cell lymphoma vaccines.
    Rieger R; Kipps TJ
    Cancer Res; 2003 Jul; 63(14):4128-35. PubMed ID: 12874017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced tumorigenesis of EG7 after interleukin-10 gene transfer and enhanced efficacy in combination with intratumorally injection of adenovirus-mediated lymphotactin and the underlying mechanism.
    Zhang J; Zhou Z; Wang C; Shen J; Zheng Y; Zhang L; Wang J; Xia D
    Cancer Immunol Immunother; 2011 Apr; 60(4):559-73. PubMed ID: 21240488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of adenoviruses encoding CD40L or IL-2 against B cell lymphoma.
    Meziane el K; Bhattacharyya T; Armstrong AC; Qian C; Hawkins RE; Stern PL; Dermime S
    Int J Cancer; 2004 Oct; 111(6):910-20. PubMed ID: 15300803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo antitumor effect of CD40L-transduced tumor cells as a vaccine for B-cell lymphoma.
    Briones J; Timmerman J; Levy R
    Cancer Res; 2002 Jun; 62(11):3195-9. PubMed ID: 12036933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of adenoviruses as oncolytics and cancer vaccines in an immunocompetent B cell lymphoma model.
    Weaver EA; Chen CY; May SM; Barry ME; Barry MA
    Hum Gene Ther; 2011 Sep; 22(9):1095-100. PubMed ID: 21770794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with adenovirus LIGHT-engineered dendritic cells induces potent T cell responses and therapeutic immunity in HBV transgenic mice.
    Jiang W; Chen R; Kong X; Long F; Shi Y
    Vaccine; 2014 Jul; 32(35):4565-4570. PubMed ID: 24951859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced antitumor immunity is elicited by adenovirus-mediated gene transfer of CCL21 and IL-15 in murine colon carcinomas.
    Zhao DX; Li ZJ; Zhang Y; Zhang XN; Zhao KC; Li YG; Zhang MM; Yu XW; Liu MY; Li Y
    Cell Immunol; 2014; 289(1-2):155-61. PubMed ID: 24838092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An NKT-mediated autologous vaccine generates CD4 T-cell dependent potent antilymphoma immunity.
    Chung Y; Qin H; Kang CY; Kim S; Kwak LW; Dong C
    Blood; 2007 Sep; 110(6):2013-9. PubMed ID: 17581919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor immunity after vaccination with B lymphoma cells overexpressing a triad of costimulatory molecules.
    Briones J; Timmerman JM; Panicalli DL; Levy R
    J Natl Cancer Inst; 2003 Apr; 95(7):548-55. PubMed ID: 12671023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumoral coinjection of two adenoviruses, one encoding the chemokine IFN-gamma-inducible protein-10 and another encoding IL-12, results in marked antitumoral synergy.
    Narvaiza I; Mazzolini G; Barajas M; Duarte M; Zaratiegui M; Qian C; Melero I; Prieto J
    J Immunol; 2000 Mar; 164(6):3112-22. PubMed ID: 10706701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous expression of allogenic class II MHC and B7.1 (CD80) molecules in A20 B-lymphoma cell line enhances tumor immunogenicity.
    Jang YJ; Nam SY; Kim MS; Seong RH; Park YS; Chung YH; Chung HY
    Mol Cells; 2002 Feb; 13(1):130-6. PubMed ID: 11911464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-mediated delivery of LIGHT to the tumor boosts natural killer cells and delays tumor progression.
    Stringhini M; Mock J; Fontana V; Murer P; Neri D
    MAbs; 2021; 13(1):1868066. PubMed ID: 33404287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes simplex virus (HSV) amplicon-mediated codelivery of secondary lymphoid tissue chemokine and CD40L results in augmented antitumor activity.
    Tolba KA; Bowers WJ; Muller J; Housekneckt V; Giuliano RE; Federoff HJ; Rosenblatt JD
    Cancer Res; 2002 Nov; 62(22):6545-51. PubMed ID: 12438249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.